Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Cauwels A et al. | Anaphylactic shock depends on PI3K and eNOS-derived NO. | 2006 | J. Clin. Invest. | pmid:16886062 |
Wolf P et al. | Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis. | 2006 | Am. J. Pathol. | pmid:16936256 |
Pirbhai M et al. | The secreted protease factor CPAF is responsible for degrading pro-apoptotic BH3-only proteins in Chlamydia trachomatis-infected cells. | 2006 | J. Biol. Chem. | pmid:16940052 |
Harputluoglu MM et al. | The effects of Gingko biloba extract on acetic acid-induced colitis in rats. | 2006 | Turk J Gastroenterol | pmid:16941250 |
Han JI et al. | RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization. | 2006 | J. Leukoc. Biol. | pmid:16565322 |
Servillo L et al. | Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages. | 2006 | FASEB J. | pmid:16571775 |
Flamand N et al. | Inhibition of platelet-activating factor biosynthesis by adenosine and histamine in human neutrophils: involvement of cPLA2alpha and reversal by lyso-PAF. | 2006 | J. Leukoc. Biol. | pmid:16501051 |
He J and Bazan HE | Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. | 2006 | Invest. Ophthalmol. Vis. Sci. | pmid:16505020 |
Barthomeuf C et al. | Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis. | 2006 | Free Radic. Biol. Med. | pmid:16458188 |
Marchand C et al. | Role of MSK1 in the signaling pathway leading to VEGF-mediated PAF synthesis in endothelial cells. | 2006 | J. Cell. Biochem. | pmid:16479592 |
Buchanan MR | Biological basis and clinical implications of acetylsalicylic acid resistance. | 2006 | Can J Cardiol | pmid:16485051 |
Wang GD et al. | Platelet-activating factor in the enteric nervous system of the guinea pig small intestine. | 2006 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:17030900 |
Herman AG and Stockwell BR | Enzyme annotation with chemical tools. | 2006 | Chem. Biol. | pmid:17052604 |
Chiang KP et al. | An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. | 2006 | Chem. Biol. | pmid:17052608 |
Brown SL et al. | Activation and regulation of platelet-activating factor receptor: role of G(i) and G(q) in receptor-mediated chemotactic, cytotoxic, and cross-regulatory signals. | 2006 | J. Immunol. | pmid:16920964 |
Baker KE et al. | Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation? | 2006 | Br. J. Pharmacol. | pmid:16921398 |
Kim DH et al. | Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion. | 2006 | Ann. Otol. Rhinol. Laryngol. | pmid:16944661 |
Vahidy WH et al. | Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. | 2006 | Exp Brain Res | pmid:16947060 |
Matsumura Y et al. | A role for inflammatory mediators in the induction of immunoregulatory B cells. | 2006 | J. Immunol. | pmid:16982922 |
Slomiany BL and Slomiany A | Porphyromonas gingivalis lipopolysaccharide-induced cytosolic phospholipase A2 activation interferes with salivary mucin synthesis via platelet activating factor generation. | 2006 | Inflammopharmacology | pmid:16983494 |
Zhang Q et al. | Activation of platelet-activating factor receptor in SZ95 sebocytes results in inflammatory cytokine and prostaglandin E2 production. | 2006 | Exp. Dermatol. | pmid:16984258 |
Hartvigsen K et al. | 1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB. | 2006 | Lipids | pmid:17069352 |
Sugimoto S et al. | Purification and characterization of lysophospholipase D from rat brain. | 2006 | Biochim. Biophys. Acta | pmid:17071136 |
Doi K et al. | Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. | 2006 | Am. J. Pathol. | pmid:16651609 |
Coleus forskohlii. Monograph. | 2006 | Altern Med Rev | pmid:16597194 | |
Fernandes CJ and O'Donovan DJ | Platelet transfusions in infants with necrotizing enterocolitis. | 2006 | Curr. Hematol. Rep. | pmid:16537050 |
Maliba R et al. | Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. | 2006 | Cell. Signal. | pmid:16617006 |
Jauchem JR | The role of autacoids and the autonomic nervous system in cardiovascular responses to radio-frequency energy heating. | 2006 | Auton Autacoid Pharmacol | pmid:16553641 |
Bi W et al. | Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates. | 2006 | Bioorg. Med. Chem. Lett. | pmid:16797986 |
Purnell ET et al. | Influence of the preimplantation embryo development (Ped) gene on embryonic platelet-activating factor (PAF) levels. | 2006 | J. Assist. Reprod. Genet. | pmid:16799834 |
Slomiany BL and Slomiany A | Cytosolic phospholipase A2 activation in Helicobacter pylori lipopolysaccharide-induced interference with gastric mucin synthesis. | 2006 | IUBMB Life | pmid:16754300 |
Moreno SE et al. | Signaling via platelet-activating factor receptors accounts for the impairment of neutrophil migration in polymicrobial sepsis. | 2006 | J. Immunol. | pmid:16818786 |
Machado EM et al. | WEB 2086, a platelet-activating factor antagonist, inhibits prophenoloxidase-activating system and hemocyte microaggregation reactions induced by Trypanosoma rangeli infection in Rhodnius prolixus hemolymph. | 2006 | J. Insect Physiol. | pmid:16777137 |
Blanchet MR et al. | Dimethyphenylpiperazinium, a nicotinic receptor agonist, downregulates inflammation in monocytes/macrophages through PI3K and PLC chronic activation. | 2006 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:16782754 |
Gomes RN et al. | Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. | 2006 | Shock | pmid:16783197 |
Chen LW et al. | Thermal injury-induced priming effect of neutrophil is TNF-alpha and P38 dependent. | 2006 | Shock | pmid:16783201 |
Fonseca FV et al. | Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom. | 2006 | Protein J. | pmid:16729248 |
Wang C et al. | Total synthesis of (+/-)-paeonilide. | 2006 | Org. Lett. | pmid:16737293 |
Kaul DK et al. | Peptides based on alphaV-binding domains of erythrocyte ICAM-4 inhibit sickle red cell-endothelial interactions and vaso-occlusion in the microcirculation. | 2006 | Am. J. Physiol., Cell Physiol. | pmid:16738001 |
Thaete LG and Neerhof MG | Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. | 2006 | Am. J. Obstet. Gynecol. | pmid:16579936 |
Karantonis HC et al. | In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. | 2006 | Nutr Metab Cardiovasc Dis | pmid:16580585 |
Balestrieri C et al. | Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis. | 2006 | Biochem. Pharmacol. | pmid:16580641 |
Poeckel D et al. | 3-O-acetyl-11-keto-boswellic acid decreases basal intracellular Ca2+ levels and inhibits agonist-induced Ca2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells. | 2006 | J. Pharmacol. Exp. Ther. | pmid:16174802 |
Mauri P et al. | LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity. | 2006 | J Pharm Biomed Anal | pmid:16343838 |
Subbanna PK and Tyagi MG | PAF antagonism modifies neuroprotective action of histone deacetylase and calcineurin phosphatase inhibitors in mice. | 2006 | Indian J. Exp. Biol. | pmid:17205708 |
Fang H et al. | Anaphylactic reaction induced by Toxoplasma gondii-derived heat shock protein 70. | 2006 | Int. Immunol. | pmid:16943259 |
Antonopoulou S et al. | Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus. | 2006 | J Med Food | pmid:17004898 |
Gomes MT et al. | Platelet-activating factor-like activity isolated from Trypanosoma cruzi. | 2006 | Int. J. Parasitol. | pmid:16337632 |
Dohi T et al. | [Role of platelet-activating factor on spinal pain transduction]. | 2006 | Nippon Yakurigaku Zasshi | pmid:16508219 |
Karidis NP et al. | Platelet-activating factor in liver injury: a relational scope. | 2006 | World J. Gastroenterol. | pmid:16773686 |